Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 20/20 | 0.49 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.49 |
| ▸ | PTGDR | Q13258 | 2/20 | 0.46 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23089018 | 1.00 | PTGER4 (0.49) | PTGER4PTGER2PTGDRPTGER3 | |
| SCHEMBL28484982 | 0.94 | PTGER4 (0.54) | PTGER4PTGER2PTGDRPTGER3 | |
| SCHEMBL1956768 | 0.94 | PTGER4 (0.54) | PTGER4PTGER2PTGDRPTGER3 | |
| SCHEMBL23089017 | 0.92 | PDE2A (0.41) | PTGER4PTGER2PTGDRPTGER3 | |
| SCHEMBL196468 | 0.92 | SRD5A2 (0.44) | PTGER4PTGER2PTGDR | |
| SCHEMBL1956758 | 0.85 | PTGER4 (0.56) | PTGER4PTGER2PTGDRPTGER3 | |
| SCHEMBL28477223 | 0.85 | PTGER4 (0.56) | PTGER4PTGER2PTGDRPTGER3 | |
| SCHEMBL196469 | 0.83 | PTGER4 (0.43) | PTGER4PTGER2PTGDRPTGER3 | |
| SCHEMBL28474778 | 0.81 | PTGER4 (0.42) | PTGER4PTGER2PTGDRPTGER3 | |
| SCHEMBL28474779 | 0.80 | SRD5A2 (0.43) | PTGER4PTGER2PTGER3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210079013-A1 | Heterobicyclic Carboxylic Acids and Salts Thereof | SHENZHEN IONOVA LIFE SCIENCE CO., LTD. (CN) | 2021-03-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210079013-A1 | Heterobicyclic Carboxylic Acids and Salts Thereof | PTGER4, PTGER1, GPR4 | PTGER4 1/4885PTGER2 9/4885PTGDR 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.